{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T23:27:33Z","timestamp":1762039653616,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV19-08-00383"],"award-info":[{"award-number":["NV19-08-00383"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006704","name":"Ostravsk\u00e1 Univerzita v Ostrav\u011b","doi-asserted-by":"publisher","award":["SGS14\/LF\/2017-2018"],"award-info":[{"award-number":["SGS14\/LF\/2017-2018"]}],"id":[{"id":"10.13039\/501100006704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>We evaluated the efficiency and toxicity of stereotactic hypofractionated boost in combination with conventionally fractionated radiotherapy in the treatment of advanced floor of the mouth cancer.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thirty-seven patients with advanced stage of the floor of the mouth cancer, histologically confirmed squamous cell carcinoma (p16 negative) ineligible for surgical treatment, were indicated for radiochemotherapy or hyperfractionated accelerated radiotherapy (HART). The radiotherapy protocol combined external beam radiotherapy (EBRT) and a stereotactic hypofractionated boost to the primary tumor. The dose delivered from EBRT was 70\u201372.5\u00a0Gy in 35\/50 fractions. The hypofractionated boost followed with 10\u00a0Gy in two fractions. For the variables\u2014tumor volume, stage and grade a multivariate analysis was performed to find the relationship between overall survival, local progression and metastasis. Toxicity was evaluated according to CTCAE scale version 4.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After a median follow-up of 16\u00a0months, 23 patients (62%) achieved complete remission. The median time to local progression and metastasis was 7\u00a0months. Local control (LC) at 2 and 5-years was 70% and 62%, respectively. Progression-free survival (PFS) and overall survival (OS) were 57% and 49% at 2\u00a0years and 41% and 27% at 5\u00a0years, respectively. Statistical analysis revealed that larger tumors had worse overall survival and a greater chance of metastasis. Log-Rank GTV\u2009&gt;\u200944 ccm (HR\u2009=\u20091.96; [95% CI (0.87; 4.38)]; <jats:italic>p<\/jats:italic>\u2009=\u20090.11). No boost-related severe acute toxicity was observed. Late osteonecrosis was observed in 3 patients (8%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The combination of EBRT and stereotactic hypofractionated boost is safe and seems to be an effective option for dose escalation in patients with advanced floor of the mouth tumors who are ineligible for surgical treatment and require a non-invasive approach.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01842-1","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T13:02:46Z","timestamp":1624971766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-9568","authenticated-orcid":false,"given":"Tom\u00e1\u0161","family":"Bla\u017eek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8668-3732","authenticated-orcid":false,"given":"Zuzana","family":"Zd\u011bblov\u00e1 \u010cerm\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2461-6606","authenticated-orcid":false,"given":"Luk\u00e1\u0161","family":"Knybel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9913-7039","authenticated-orcid":false,"given":"Pavel","family":"Hurn\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1974-3096","authenticated-orcid":false,"given":"Jan","family":"\u0160temb\u00edrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0656-9084","authenticated-orcid":false,"given":"Kamila","family":"Resov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8988-2286","authenticated-orcid":false,"given":"Tereza","family":"Para\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5759-2073","authenticated-orcid":false,"given":"Martin","family":"Form\u00e1nek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1579-1792","authenticated-orcid":false,"given":"Jakub","family":"Cvek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Soumarov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"7","key":"1842_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1067\/mcd.2001.109374","volume":"47","author":"AY Chen","year":"2001","unstructured":"Chen AY, Myers JN. Cancer of the oral cavity. Dis Mon. 2001;47(7):275\u2013361.","journal-title":"Dis Mon"},{"key":"1842_CR2","doi-asserted-by":"crossref","unstructured":"Saggi S, Badran KW, Han AY, Kuan EC, John MA. Clinicopathologic characteristic and survival outcomes in the floor of mouth squamous cell carcinoma: A population-based study. Otolaryngol Head Neck Surg 2018;159(1):51\u201358.","DOI":"10.1177\/0194599818756815"},{"issue":"4","key":"1842_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/0194599817746909","volume":"158","author":"MA Ellis","year":"2018","unstructured":"Ellis MA, Graboyes EM, Wahlquist AE, Neskey DM, Kaczmar JM, Schopper HK. Primary surgery vs radiotherapy for early oral cavity cancer. Otolaryngol Head Neck Surg. 2018;158(4):649\u201359.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1842_CR4","doi-asserted-by":"crossref","unstructured":"Fujiwara R, Burtness B, Husain ZA, Judson BL, Bhatia A, Sasaki C. Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: primary surgical resection vs nonsurgical treatment. Oral Oncol 2017;71:129\u2013137.","DOI":"10.1016\/j.oraloncology.2017.06.013"},{"key":"1842_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/0194599817746909","volume":"158","author":"MA Ellis","year":"2018","unstructured":"Ellis MA, Graboyes EM, Wahlquist AE, Neskey DM, Kaczmar JM, Schopper HK, et al. Primary surgery vs radiotherapy for early stage oral cavity cancer. Otolaryngol Head Neck Surg. 2018;158:649\u201359.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"1842_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3342\/ceo.2011.4.1.1","volume":"4","author":"TJ Ow","year":"2011","unstructured":"Ow TJ, Myers JN. Current management of advanced resectable oral cavity squamous cell carcinoma. Clin Exp Otorhinolaryngol. 2011;4(1):1\u201310.","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"1842_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.radonc.2020.08.013","volume":"154","author":"A Hosni","year":"2020","unstructured":"Hosni A, Chiu K, Huang SH, Xu W, Huang J, Bayley A. Non-operative management for oral cavity carcinoma: definitive radiation therapy as a potential alternative treatment approach. Radiother Oncol. 2020;154:70\u20135.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1842_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ijrobp.2005.02.025","volume":"63","author":"M Yao","year":"2005","unstructured":"Yao M, et al. Intensity-modulated radiation therapy for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005;63(2):410\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1842_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0936-6555(98)80055-1","volume":"10","author":"AG Robertson","year":"1998","unstructured":"Robertson AG, et al. Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumors. Clin Oncol. 1998;10(3):155\u201360.","journal-title":"Clin Oncol"},{"key":"1842_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00066-007-1663-8","volume":"183","author":"G Studer","year":"2007","unstructured":"Studer G, Luetolf UM, Glanzmann C. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Strahlenther Onkol. 2007;183:417\u201323.","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"1842_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.clon.2019.12.004","volume":"32","author":"D Atwell","year":"2020","unstructured":"Atwell D, Elks J, Cahill K, Hearn D. A review of modern radiation therapy dose escalation in locally advanced head and neck cancer. Clin Oncol. 2020;32(5):330\u201341.","journal-title":"Clin Oncol"},{"key":"1842_CR12","doi-asserted-by":"crossref","unstructured":"Studer G, et. al. Osteoradionecrosis of the mandible. minimized risk profile following intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 2006;182(5):283\u2013288.","DOI":"10.1007\/s00066-006-1477-0"},{"issue":"2","key":"1842_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0167-8140(97)00092-3","volume":"44","author":"L Lozza","year":"1997","unstructured":"Lozza L, et al. Analysis of risk factors for mandibular bone radionecrosis after exclusive low dose-rate brachytherapy for oral cancer. Radiother Oncol. 1997;44(2):143\u20137.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1842_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.radonc.2016.10.008","volume":"122","author":"G Kov\u00e1cs","year":"2017","unstructured":"Kov\u00e1cs G, Martinez-Monge R, Budrukkar A, Guinot J, Johansson B, Strnad V. GEC-ESTRO ACROP recommendations for head and neck brachytherapy in squamous cell carcinomas: 1st update\u2014improvement by cross-sectional imaging-based treatment planning and stepping source technology. Radiother Oncol. 2017;122(2):248\u201354.","journal-title":"Radiother Oncol"},{"key":"1842_CR15","doi-asserted-by":"crossref","unstructured":"Julianna R, Voichita Bar-Ad, Cognetti D, Curry J, et al. A systemic review of treating head and neck cancer: a reintroduction of brachytherapy with or without surgery. J Contemp Brachytherapy 2018;10,5:454\u2013462.","DOI":"10.5114\/jcb.2018.79399"},{"issue":"4","key":"1842_CR16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ijrobp.2020.04.030","volume":"108","author":"AR Zeno","year":"2020","unstructured":"Zeno AR, Gouw MD, Matthew D, et al. Single-center prospective trial investigating the feasibility of seri\u00e1l FDG-PET guided adaptive radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2020;108(4):960\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1842_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13014-020-01718-w","volume":"15","author":"P Vempati","year":"2020","unstructured":"Vempati P, Halthore A, Teckie S, et al. Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavourable locally advanced oropharyngeal cancer. Radiat Oncol. 2020;15:278\u201388.","journal-title":"Radiat Oncol"},{"issue":"6","key":"1842_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/COC.0b013e3180ca7cb1","volume":"30","author":"BK Chang","year":"2007","unstructured":"Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 2007;30(6):637\u201344.","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"1842_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00066-012-0128-x","volume":"188","author":"J Cvek","year":"2012","unstructured":"Cvek J, Kubes J, Skacelikova E, Otahal B, Kominek P, Halamka M, Feltl D. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70\u201375Gy in 5 weeks for advanced head and neck cancer. Strahlenter Onkol. 2012;188(8):666\u201370.","journal-title":"Strahlenter Onkol"},{"key":"1842_CR20","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.oraloncology.2013.07.007","volume":"49","author":"A Al-Mamgani","year":"2013","unstructured":"Al-Mamgani A, Van Rooij P, Sewnaik A, Mehilal R, et al. Brachytherapy or stereotactic body radiotherapy boost for early-stage oropharyngeal cancer: comparable outcomes of two different approaches. Oral Oncol. 2013;49:1018\u201324.","journal-title":"Oral Oncol"},{"key":"1842_CR21","doi-asserted-by":"crossref","unstructured":"Strnad V. Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy. Strahlenther Onkol 2004;180(11):710\u2013717.","DOI":"10.1007\/s00066-004-9196-x"},{"issue":"3","key":"1842_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0167-8140(91)90036-G","volume":"21","author":"DP Dearnaley","year":"1991","unstructured":"Dearnaley DP, et al. Interstitial irradiation for carcinoma of the tongue and floor of the mouth: Royal Marsden Hospital Experience 1970\u20131986. Radioher Oncol. 1991;21(3):183\u201392.","journal-title":"Radioher Oncol"},{"issue":"5","key":"1842_CR23","first-page":"345","volume":"13","author":"BK Mohanti","year":"2001","unstructured":"Mohanti BK, Bansal M, Bahadur S, Shukla NK, Deo SV, Prabhakar R, Rath GK. Interstitial brachytherapy with or without external beam irradiation in head and neck cancer: Institute Rotary Cancer Hospital experience. Clin Oncol (R Coll Radiol). 2001;13(5):345\u201352.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1842_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.radonc.2013.05.021","volume":"107","author":"G Sanguienti","year":"2013","unstructured":"Sanguienti G, Rao N, Gunn B, et al. Predictors of PEG dependence after IMRT\u00b1 chemotherapy for oropharyngeal cancer. Radiother Oncol. 2013;107:300\u20134.","journal-title":"Radiother Oncol"},{"key":"1842_CR25","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1200\/JCO.2009.24.6199","volume":"28","author":"FY Feng","year":"2010","unstructured":"Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol. 2010;28:2732\u20138.","journal-title":"J Clin Oncol"},{"key":"1842_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.oraloncology.2018.03.008","volume":"80","author":"CC Foster","year":"2018","unstructured":"Foster CC, Melotek JM, Brisson RJ, Seiwert TY, Cohen EE, Stenson KM, et al. Definitive chemoradiation for locally-advanced oral cavity cancer: a 20-year experience. Oral Oncol. 2018;80:16\u201322.","journal-title":"Oral Oncol"},{"key":"1842_CR27","first-page":"5755","volume":"34","author":"H Yamazaki","year":"2014","unstructured":"Yamazaki H, Ogita M, Himei K, et al. Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck, a multi-institutional survey: impact of planning target volume. Anticancer Res. 2014;34:5755\u201360.","journal-title":"Anticancer Res"},{"key":"1842_CR28","doi-asserted-by":"crossref","unstructured":"Decroix Y, Ghossein NA. Experience of the Curie Institute in treatment of cancer of the mobile tongue: I. Treatment policies and result. Cancer 1981;47(3):496\u2013502.","DOI":"10.1002\/1097-0142(19810201)47:3<496::AID-CNCR2820470312>3.0.CO;2-Q"},{"issue":"3","key":"1842_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0924-4212(96)81500-3","volume":"82","author":"M Pernot","year":"1995","unstructured":"Pernot M, et al. Evaluation of the importance of systematic neck dissection in carcinoma of the oral cavity treated by brachytherapy alone for the primary lesion (apropos of a series of 346 patients). Bull Cancer Radiother. 1995;82(3):311\u20137.","journal-title":"Bull Cancer Radiother"},{"key":"1842_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.oraloncology.2015.04.007","volume":"51","author":"EF Scher","year":"2015","unstructured":"Scher EF, Romesser PB, Chen C, Ho F, Wuu Y, Sherman EJ, et al. Definitive chemoradiation for primary oral cavity carcinoma: a single institution experience. Oral Oncol. 2015;51:709\u201315.","journal-title":"Oral Oncol"},{"key":"1842_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejca.2019.04.015","volume":"116","author":"T Eder","year":"2019","unstructured":"Eder T, Hess AK, Konschak C, Stromberger K, J\u00f6hrens K, Fleischer V, et al. Interference of tumour mutational burden with the outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group. Eur J Cancer. 2019;116:67\u201376.","journal-title":"Eur J Cancer"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01842-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01842-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01842-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T13:11:16Z","timestamp":1624972276000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01842-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01842-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"type":"electronic","value":"1748-717X"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients agreed to participate in the study by signing informed consent. The study was ethicaly approved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Publication has been approved by all co-authors and they agree with publication","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}